Evaluation of the effectiveness of erbium yttrium–aluminum–garnet fractional laser, carbon dioxide therapy and platelet-rich plasma in treating striae distensae

Mahrous, Enas A.M.

doi:10.4103/ejdv.ejdv_37_17

Cited by 2 publications

(5 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This observation was contrary to the reports of Manjunathachar et al (2020) and Sadik et al (2012), who respectively, found that women less than or equal to 24 years old, and women within 25 to 30 years old, had the highest levels of seropositivity. Dinkar and Singh (2020) reported that the highest seropositivity of ToRCH (43.15%) was in the age group 15-25 years.…”

Section: Resultscontrasting

confidence: 93%

“…prevalence varies from one geographical area to the other (Surpam, 2006). Previous studies among pregnant women have shown IgM seropositivity to be 61.1% in central India (Manjunathachar et al, 2020) and 39.5% in Tanzania (Saajan et al, 2017). In Egypt, the overall prevalence of ToRCH infection was 98.8%, according to Nirmal et al (2017).…”

Section: Okonko I O Ogbonnia M a Okonko B J Onu E N And Igwe Mu: Seru...mentioning

confidence: 87%

“…ToRCH infections are important causes of maternal and fetal morbidity and mortality. The infection's risk of harming the fetus is often more outstanding if the mother is infected in early pregnancy (Mahrous, 2018). In most cases, maternal illness due to ToRCH infections is mild, but the impact on the developing fetus is more severe (Boyer & Boyer, 2004).…”

Section: Okonko I O Ogbonnia M a Okonko B J Onu E N And Igwe Mu: Seru...mentioning

confidence: 99%

See 2 more Smart Citations

Serum antibodies against ToRCH agents in pregnant women presenting at a tertiary hospital in Port Harcourt, Nigeria.

Okonko,

Ogbonnia,

Okonko

et al. 2024

View full text Add to dashboard Cite

ToRCH infections pose a great risk to the fetus and neonates if the mother is actively infected during pregnancy. This may lead to miscarriage, stillbirth, delayed fetal growth and maturation (intrauterine growth retardation), or pre-term delivery. This study aimed to evaluate the prevalence of ToRCH infections in pregnant women in Port Harcourt. Sera from 84 pregnant women between the ages of 16 and 45 were analysed for detectable ToRCH IgM antibodies using the Dia-Pro ToRCH IgM kit. The results from the study showed an IgM seroprevalence rate of 82.1%, with the highest rate of seropositivity obtained among married women (91.0%), Civil servants (92.3%) and women within the age group 25-34 years (92.9%). There was significant relationship between the ToRCH IgM seropositivity and age, marital status and occupational status. The seropositivity of ToRCH agents among pregnant women in Port Harcourt is high, suggesting an acute infection which may adversely affect fetal health. This underscores the need for preventive antenatal screening and universal immunization schemes.

show abstract

Section: Resultscontrasting

confidence: 93%

Section: Okonko I O Ogbonnia M a Okonko B J Onu E N And Igwe Mu: Seru...mentioning

confidence: 87%

Section: Okonko I O Ogbonnia M a Okonko B J Onu E N And Igwe Mu: Seru...mentioning

confidence: 99%

See 1 more Smart Citation

Serum antibodies against ToRCH agents in pregnant women presenting at a tertiary hospital in Port Harcourt, Nigeria.

Okonko,

Ogbonnia,

Okonko

et al. 2024

View full text Add to dashboard Cite

show abstract

“…PRP: efficient treatment for striae rubrae, especially on the trunk 28 . Combinations: Er:YAG laser, carboxytherapy and PRP: Effective for both types of SD, but Er:YAG laser is safer and more effective 39 . Light therapies, especially IPL and UVB therapy, are effective treatments for both striae types.…”

Section: Resultsmentioning

confidence: 99%

“…28 Combinations: Er:YAG laser, carboxytherapy and PRP: Effective for both types of SD, but Er: YAG laser is safer and more effective. 39 Light therapies, especially IPL and UVB therapy, are effective treatments for both striae types. Topical therapies, especially those containing tretinoin, glycolic acid, L-ascorbic acid, succinylated collagen and herbal extracts, are appropriate for SD treatment.…”

Section: Therapeutic Comparisonsmentioning

confidence: 99%

Systematic review of single and combined treatments for different types of striae: a comparison of striae treatments

Seirafianpour

Sodagar

Mozafarpoor

et al. 2021

Acad Dermatol Venereol

View full text Add to dashboard Cite

Striae distensae (SD) or stretch marks are among the most common forms of atrophic scarring and cosmetic problems, especially in women, that negatively affect quality of life. The main causes of SD vary widely, but the most significant ones include obesity, pregnancy, high corticosteroid levels, weight changes, endocrine disorders and genetic predispositions. Various modalities are available for the treatment of SD; however, there is still no gold standard therapy for this condition. Given the many questions concerning the preferred therapeutic modalities for SD or their overall costeffectiveness, this comprehensive systematic review discusses the most prevalent, recent and promising therapies for SD in three main categories, including single therapy, therapeutic comparisons and combination therapy. A systematic search was carried out in Medline, Scopus, Web of Science and Google Scholar for original articles published on the treatment of SD by 20 May 2019. One hundred articles were reviewed and divided into three categories. In the single therapy category, we found that laser and other light-based devices and topical treatments are the most commonly applied interventions. In the therapeutic comparison category, we found that most of the common therapeutic modalities are equally effective and there is no significant difference between them in side-effects and treatment duration. In the combination therapy category, we found that the combination of two or more modalities is usually better than using each one alone.

show abstract

Evaluation of the effectiveness of erbium yttrium–aluminum–garnet fractional laser, carbon dioxide therapy and platelet-rich plasma in treating striae distensae

Cited by 2 publications

References 2 publications

Serum antibodies against ToRCH agents in pregnant women presenting at a tertiary hospital in Port Harcourt, Nigeria.

Serum antibodies against ToRCH agents in pregnant women presenting at a tertiary hospital in Port Harcourt, Nigeria.

Systematic review of single and combined treatments for different types of striae: a comparison of striae treatments

Contact Info

Product

Resources

About